Back to discover
Drug
Picrotoxin
Research stageEmerging researchRising momentum
3
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Research2013-08-01The Journal of neuroscience : the official journal of the Society for Neuroscience
Research2011-04-05Molecular psychiatry
Research2004-09-01The Journal of neuroscience : the official journal of the Society for Neuroscience
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Picrotoxin
RxNorm CUI
2539172
ChEMBL ID
CHEMBL1908342
UNII
ZLT174DL7U
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Publications over time
20042013
Most influential
Recent papers
Major research themes1
Nanostructures1
Journals, researchers & institutions
Top journals
- The Journal of neuroscience : the official journal of the Society for Neuroscience2
- Molecular psychiatry1
Leading researchers
- Auberson YP1
- Bashir ZI1
- Brown MW1
- Cardin JA1
- Carlén M1
- Choquet D1
- Collingridge GL1
- Constals A1
Leading institutions
free-text, unnormalised
- Medical Research Council Centre for Synaptic Plasticity1
- Picower Institute for Learning and Memory1
- University of Bordeaux1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature